跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Guaicare - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Guaicare
Approved
STANDARD
Guaicare
J.M. Tolmann Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
72ccd712d06ffae2
Company
J.M. Tolmann Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
72ccd712d06ffae2
Drug Approval Philippines Name
Guaicare
Product Name
Guaicare
Registration Number
DRP-2742-11
Brand Name
Guaicare
Generic Name
Guaifenesin + Salbutamol (As Sulfate)
Dosage Form
Syrup
Dosage Strength
50mg/1mg per 5mL
Manufacturer
J.M. Tolmann Laboratories, Inc.
Distributor
Care First Trading
Issuance Date
28 December 2021
Expiry Date
25 November 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
72ccd712d06ffae2
Type
Standard
Back to Philippines FDA Approvals